4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001301120-25-000037
Chief Scientific Officer sold 5,673 shares at $2.67 ($15,168)
- Chief Scientific Officer acquired 5,673 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moreadith Randall · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,673 | $0.06 | $340 | 5,673 | D |
| 2025-12-22 | Sale : show line 2 in the form 10b5-1 | −5,673 | $2.67 | $15,168 | 0 | D |
| Open-market sales · 5,673 sh · avg $2.67 · $15,168 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-22 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −5,673 | 356,286 | D |
Loading xslF345X05/wk-form4_1766516671.xml…